These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12018779)

  • 41. A likelihood-based, counterfactual approach to accounting for treatment failures in clinical trials.
    Shaffer ML; Chinchilli VM
    J Biopharm Stat; 2003 Aug; 13(3):481-94. PubMed ID: 12921395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A monotone data augmentation algorithm for multivariate nonnormal data: With applications to controlled imputations for longitudinal trials.
    Tang Y
    Stat Med; 2019 May; 38(10):1715-1733. PubMed ID: 30565281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A structured approach to choosing estimands and estimators in longitudinal clinical trials.
    Mallinckrodt CH; Lin Q; Lipkovich I; Molenberghs G
    Pharm Stat; 2012; 11(6):456-61. PubMed ID: 22962024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Placebo response in clinical trials with schizophrenia patients.
    Kinon BJ; Potts AJ; Watson SB
    Curr Opin Psychiatry; 2011 Mar; 24(2):107-13. PubMed ID: 21285702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-response relationship from longitudinal data with response-dependent dose modification using likelihood methods.
    Funatogawa I; Funatogawa T
    Biom J; 2012 Jul; 54(4):494-506. PubMed ID: 22641310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generalizability in nongaussian longitudinal clinical trial data based on generalized linear mixed models.
    Vangeneugden T; Molenberghs G; Laenen A; Alonso A; Geys H
    J Biopharm Stat; 2008; 18(4):691-712. PubMed ID: 18607802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bayesian subset analysis.
    Dixon DO; Simon R
    Biometrics; 1991 Sep; 47(3):871-81. PubMed ID: 1742443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixture models for the joint distribution of repeated measures and event times.
    Hogan JW; Laird NM
    Stat Med; 1997 Jan 15-Feb 15; 16(1-3):239-57. PubMed ID: 9004395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conditional generalized estimating equations for the analysis of clustered and longitudinal data.
    Goetgeluk S; Vansteelandt S
    Biometrics; 2008 Sep; 64(3):772-780. PubMed ID: 18047524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reserpine added to neuroleptic-tricyclic in refractory schizophrenics.
    Bacher N; Lewis H
    J Clin Psychiatry; 1981 Aug; 42(8):326. PubMed ID: 7019202
    [No Abstract]   [Full Text] [Related]  

  • 51. A shared parameter model for the estimation of longitudinal concomitant intervention effects.
    Wu CO; Tian X; Jiang W
    Biostatistics; 2011 Oct; 12(4):737-49. PubMed ID: 21262930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short notes on maximum likelihood inference for control-based pattern-mixture models.
    Tang Y
    Pharm Stat; 2015; 14(5):395-9. PubMed ID: 26178475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statistical analysis of repeated measurements with informative censoring times.
    Sun J; Song PX
    Stat Med; 2001 Jan; 20(1):63-73. PubMed ID: 11135348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Present condition of and future perspective for antipsychotic agents--guidelines on clinical investigation of medical products in the treatment of depression].
    Higuchi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):167. PubMed ID: 22195323
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative clinical study of the antidepressive effects of melitracence and a metabolite of thioridazine].
    Vencovský E; Sedivec V; Peterová E; Baudis P
    Act Nerv Super (Praha); 1968 Oct; 10(3):291. PubMed ID: 4883237
    [No Abstract]   [Full Text] [Related]  

  • 56. A local influence approach applied to binary data from a psychiatric study.
    Jansen I; Molenberghs G; Aerts M; Thijs H; Van Steen K
    Biometrics; 2003 Jun; 59(2):410-9. PubMed ID: 12926726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depression and the acute schizophrenic process.
    Rada RT; Donlon PJ
    Psychosomatics; 1975; 16(3):116-9. PubMed ID: 810823
    [No Abstract]   [Full Text] [Related]  

  • 58. Techniques for incorporating longitudinal measurements into analyses of survival data from clinical trials.
    Troxel AB
    Stat Methods Med Res; 2002 Jun; 11(3):237-45. PubMed ID: 12094757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Aspects of treatment with imipramine (Antideprin) in schizophrenia].
    Belciugăţeanu C; Vrabie E; Stefănescu P
    Neurol Psihiatr Neurochir; 1969; 14(4):377-83. PubMed ID: 5361688
    [No Abstract]   [Full Text] [Related]  

  • 60. Latent mixture models for multivariate and longitudinal outcomes.
    Pickles A; Croudace T
    Stat Methods Med Res; 2010 Jun; 19(3):271-89. PubMed ID: 19608600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.